APA (7th ed.) Citation

Y, S., C, S., D, H., E, N., V, F., G, H., . . . L, S. (2023). The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes. Medical care, 61(3), 157. https://doi.org/10.1097/MLR.0000000000001816

Chicago Style (17th ed.) Citation

Y, Shao, et al. "The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes." Medical Care 61, no. 3 (2023): 157. https://doi.org/10.1097/MLR.0000000000001816.

MLA (9th ed.) Citation

Y, Shao, et al. "The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes." Medical Care, vol. 61, no. 3, 2023, p. 157, https://doi.org/10.1097/MLR.0000000000001816.